NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Depression can be challenging to treat. Many people eventually find relief, but it can take trying talk therapy, medications, and more to get there. If you've already tried therapy and antidepressants without finding relief, you may have talked to your provider about transcranial magnetic stimulation (TMS). Since TMS is a treatment some providers are still gaining familiarity with, even after discussing it, you may be left wondering if TMS is right for you.
TMS therapy is an FDA-cleared method for treating major depressive disorder (MDD) and other conditions. It works by using a non-invasive handheld device to deliver soft magnetic pulses that stimulate areas of the brain associated with mood regulation.
TMS treatment typically takes place five days a week over the course of six to nine weeks, with each session lasting about 30 minutes. Side effects are minimal and typically subside quickly. Some mild reactions include headache, scalp discomfort, and slight tingling in facial muscles.
To help you determine whether TMS therapy is right for you, consider the following four questions.
To receive TMS therapy for depression and have it covered by your insurance, you will need a diagnosis of MDD, also known as clinical depression. A therapist or psychiatrist can evaluate you by asking you a series of questions, including how long you have been feeling depressed, how your appetite and sleep are, if you are experiencing fatigue or a lack of focus, and how these symptoms are affecting your life.
While TMS is also FDA-cleared for other conditions also, it has been used mostly in
patients with major depressive disorder, with
more than 50 percent of individuals studied responding that their symptoms were reduced in intensity by half. Nearly 40 percent enjoyed remission or a complete absence of symptoms.
TMS is not considered a first-line treatment, so your insurer will typically want to see at least two ineffective medication attempts before it will pay for your TMS treatment. Your insurer may also want to see that you have tried evidence-based psychotherapy, such as cognitive behavioral therapy (CBT). However, given that one-third of people continue experiencing depression symptoms even after trying two medications, you may be among those who qualify for TMS and have their treatment covered by insurance.
While TMS is generally associated with a low side effect profile, there are conditions that can make TMS treatment impossible. For example, if you have non-removable metal in your head, you are not a candidate for TMS. This includes aneurysm clips or coils, stents in the neck or brain, and deep brain stimulators. However, cavity fillings and braces are no problem. You will also want to inform your provider if you have epilepsy, bipolar disorder, or a substance use disorder. Also, your doctor might ask you about your alcohol use. These are not necessarily impediments to treatment, but letting your doctor know that you have one of these conditions can help them identify slightly different side effects. Since mild headaches are one of the few side effects of TMS, be sure to let your technician know if you experience frequent headaches so they can adjust your treatment accordingly.
Thanks for subscribing to our list!
While individual sessions are brief and allow you to continue with your day afterward, the total time for a TMS course of treatment is not insignificant. But as time for self-care, it is time well spent. In fact, many patients say that stepping outside their normal routine to take this time for themselves was an unexpectedly rewarding part of their TMS treatment. At the same time, no treatment works in isolation, so you should also aim to maintain other self-care habits, such as exercise, meditation, and journaling.
Is TMS Therapy Right for Me? Learn More
If you've tried several treatment strategies and are still experiencing depression, know that you are not alone and that there is hope for relief. Taking time to consider the questions posed above will help you feel more confident about your path forward, but don't hesitate to schedule a no-cost consultation to have more of your questions answered.
If you've tried several treatment strategies and are still experiencing depression, know that you are not alone and that there is hope for relief. Taking time to consider the questions posed above will help you feel more confident about your path forward, but don't hesitate to schedule a no-cost consultation to have more of your questions answered.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.